Industry Insights
Cultured Meat: Moving Towards Griddle Parity
Industry InsightIn this interview, Jim Mellon discusses some of the challenges that companies in the cultured meat sector face, how they are responding and what could be in store for the field over the next few years.
Why Patient-Generated Health Data Could Power the Next Era of Clinical Research
Industry InsightLeveraging patient-generated health data (PGHD) in healthcare and clinical trials has become significantly easier with the advent of digitalization. We spoke to Alison Bourke, scientific director for real world insights at IQVIA and past president of the International Society for Pharmacoepidemiology, about how PGHD is collected, why it is useful and how we can best safeguard sensitive data.
Read More
Cytisinicline: A Treatment To Help People Battling Nicotine Addiction
Industry InsightThe pharmaceutical company Achieve Life Sciences is focused on addressing one of the biggest public health threats globally – tobacco use. Technology Networks had the pleasure of speaking with the company's chief medical officer Cindy Jacobs, MD, PhD, to learn more about cytisinicline, a plant-based alkaloid the company is currently developing as a smoking cessation treatment.
Read More
A Bright Future for Sports Neuroscience During the COVID-19 Pandemic
Industry InsightThe growing field of sports neuroscience examines the poorly studied relationship between our nervous systems and performance in sporting activities. In this Insight, sports neuroscientist Kamil Celoch discusses the field with Jaime Tartar, professor in the Department of Psychology and Neuroscience at Nova Southeastern University, Florida.
Read More
Behind the World-First Export of Jamaican Psilocybin Mushrooms
Industry InsightMydecine Innovations Group recently announced that it had completed the first harvest and commercial export of legal psychedelic psilocybin mushrooms from Jamaica to Canada. We spoke with Mydecine’s chief scientific officer and co-founder, Rob Roscow, to find out more.
Read More
Empowering Consumers With Point-of-Care Blood Testing
Industry InsightIn this interview, Technology Networks spoke with Dr Dena Marrinucci, Truvian chief operating officer and co-founder, to learn more about the limitations of the current blood testing process and the role of point-of-care blood testing in driving healthier outcomes.
Read More
Meeting Renewed Regulatory Focus on Gene Therapy Safety Standards
Industry InsightIn this industry insights piece, we explore how gene therapies represent a rapidly growing new paradigm — both therapeutically and with respect to how they are managed within the larger scope of healthcare — and how this has wide-ranging impacts on several key areas, including regulation.
Read More
New Test Enables Non-Invasive Detection of Endometrial Cancer
Industry InsightArquer Diagnostics is developing non-invasive tests for diagnosing and monitoring cancer, using patented technology to detect the cancer biomarker MCM5. Technology Networks had the pleasure of speaking with Nadia Whittley, Chief Executive Officer of Arquer Diagnostics, to learn more about the study and its significance.
Read More
Measuring the Antibody Response to SARS-CoV-2
Industry InsightTo learn more about the ways that antibody tests are being used in the pandemic, Technology Networks spoke to Heather-Read Harper, European Senior Manager for Immunoassay and Clinical Chemistry at Beckman Coulter.
Read More
Eliciting the Hormetic Effect: The Importance of Plant Alkaloids for Treatment of Inflammation
Industry InsightToday, plant alkaloids are attracting notice as novel therapies for conditions involving inflammation, such as metabolic syndrome, autoimmune disease and even for aging, which are often characterized by chronic, low-grade over-activation of the immune system. This piece takes a closer look at the need for novel treatments and the best uses for plant alkaloids.
Read More
